LearnGlossaryMarketStocksSuperinvestorsSign in

GDRX

GoodRx Holdings, Inc.

Healthcare · $1.1B market cap

Verdict

Share price

$3.28

close of Oct 3, 2026

Fair value

$5.63

Sticker Price

Payback Price

$2.25

buy price

Undervalued

GDRX is Undervalued: at $3.28 it trades 42% below its fair value of $5.63. Its buy price (Payback Price) is $2.25, 31% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 1% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth88.5% a year✓
Equity per share growth-3.7% a year✗
Sales growth26.0% a year✓
Free cash flow growth14.0% a year✓
Return on invested capital2.1%✗

Follow GDRX

Get notified when it reaches its buy price of $2.25. Free.

Create a free account

Insider activity

Since Jun 15, 2026: no open-market purchases, 13 sales worth $8.1M and 41 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-26

Sold

$1.5M

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-26

Sold

$739K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-26

Sold

$750K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-25

Sold

$218K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-25

Sold

$221K

Show all 13 sales

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-24

Sold

$247K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-24

Sold

$250K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-21

Sold

$477K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-21

Sold

$484K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-20

Sold

$753K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-20

Sold

$822K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-19

Sold

$827K

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-19

Sold

$839K

Other filings

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-19

J-Other

1,142,357 shares

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-19

J-Other

3,596,648 shares

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-19

C-Conversion

2,504,097 shares

FRANCISCO PARTNERS IV, L.P.

Owns 10%+ · 2026-08-19

C-Conversion

4,995,903 shares

Fengler Justin

See Remarks · 2026-08-15

Tax withholding

$17K

Show all 41 other filings

Fengler Justin

See Remarks · 2026-08-15

Tax withholding

$11K

Fengler Justin

See Remarks · 2026-08-15

Option exercise

10,149 shares

Fengler Justin

See Remarks · 2026-08-15

Option exercise

6,423 shares

Fengler Justin

See Remarks · 2026-08-15

Tax withholding

$10K

Fengler Justin

See Remarks · 2026-08-15

Tax withholding

$42K

Fengler Justin

See Remarks · 2026-08-15

Option exercise

25,568 shares

Fengler Justin

See Remarks · 2026-08-15

Option exercise

6,392 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Tax withholding

$2K

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Option exercise

1,252 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Tax withholding

$3K

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Option exercise

1,686 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Tax withholding

$5K

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Tax withholding

$9K

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Option exercise

2,636 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-08-15

Option exercise

4,541 shares

Fengler Justin

See Remarks · 2026-08-10

Award

190,204 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-07-15

Tax withholding

$9K

Chan Thomas (TC)

Chief Accounting Officer · 2026-07-15

Option exercise

5,792 shares

Barnes Wendy Lynn

See Remarks · 2026-07-15

Tax withholding

$151K

Barnes Wendy Lynn

See Remarks · 2026-07-15

Tax withholding

$67K

Barnes Wendy Lynn

See Remarks · 2026-07-15

Option exercise

51,177 shares

Barnes Wendy Lynn

See Remarks · 2026-07-15

Tax withholding

$145K

Barnes Wendy Lynn

See Remarks · 2026-07-15

Option exercise

110,963 shares

Barnes Wendy Lynn

See Remarks · 2026-07-15

Option exercise

115,148 shares

McGinnis Christopher A

See Remarks · 2026-07-15

Tax withholding

$49K

McGinnis Christopher A

See Remarks · 2026-07-15

Option exercise

36,988 shares

Wagner Scott

director · 2026-06-16

Award

73,434 shares

Bezdek Trevor

director · 2026-06-16

Award

73,434 shares

Bruehlman Ronald E

director · 2026-06-16

Award

73,434 shares

Hirsch Douglas Joseph

director · 2026-06-16

Award

73,434 shares

Kennedy Kelly J.

director · 2026-06-16

Award

73,434 shares

REY-GIRAUD AGNES

director · 2026-06-16

Award

73,434 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-06-15

Tax withholding

$3K

Chan Thomas (TC)

Chief Accounting Officer · 2026-06-15

Option exercise

1,969 shares

Chan Thomas (TC)

Chief Accounting Officer · 2026-06-15

Tax withholding

$3K

Chan Thomas (TC)

Chief Accounting Officer · 2026-06-15

Option exercise

2,100 shares

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works